Efficacy of Vaccination and Revaccination Against Hepatitis B Virus Using 2 Different Strategies in Patients With Inflammatory Bowel Disease.
Panagiotis MarkopoulosKonstantinos KarmirisIoannis DimasEvangelos VoudoukisSpyridon SiakavellasGeorgios AxiarisEirini ZacharopoulouEvanthia ZampeliEftychia TsironiMaria TzouvalaGeorgios PapatheodoridisGeorgios BamiasPublished in: Inflammatory bowel diseases (2024)
IBD patients demonstrate lower response to HBV vaccination compared with the general population. Age, body mass index, type, disease activity, and immunosuppression negatively affect the response. Half of nonresponders may benefit from an enhanced revaccination attempt.
Keyphrases
- hepatitis b virus
- disease activity
- body mass index
- rheumatoid arthritis
- patients with inflammatory bowel disease
- systemic lupus erythematosus
- end stage renal disease
- liver failure
- rheumatoid arthritis patients
- ejection fraction
- newly diagnosed
- chronic kidney disease
- ankylosing spondylitis
- prognostic factors
- peritoneal dialysis
- juvenile idiopathic arthritis
- weight gain
- patient reported